MRCY is walking into its August 18 earnings release with call buyers dominating options and short sellers continuing their slow retreat — a positioning backdrop that has grown more bullish since the August 11 report rather than resetting to neutral.
The options story remains the standout. The put/call ratio has edged up to 0.28 from its post-earnings floor near 0.23, but is still running well below the 20-day average of 0.48 — roughly 0.73 standard deviations light on downside protection. That is a meaningful shift from early August, when the PCR briefly crossed 1.10 ahead of the prior print. Call buyers are still in control, and there is no sign the defensive hedging that typically builds ahead of an earnings event has returned. Short interest reinforces the picture: bears hold 7.96% of the free float, down about 3.6% on the week, continuing the drift lower from a July peak above 5.0 million shares. Borrow remains frictionless — availability is running at 491% of short interest and cost-to-borrow has slipped further to 0.43%, near the bottom of its recent range. The lending market offers no mechanical pressure in either direction.
The analyst debate is where the tension lives. Piper Sandler initiated coverage this week with an Overweight rating and a $126 target, the most constructive fresh call on the name. JP Morgan is more measured, holding Neutral with a $101 target after nudging it up from $99 in July. Goldman Sachs remains the outlier, maintaining a Sell with a $68 target — a reading that looks increasingly disconnected given the stock is trading at $111. Bulls point to EBITDA margin expansion of more than 1,000 basis points year-over-year and free cash flow that jumped 356% to $119 million, alongside a 31% revenue surge in the high-value Modules and Sub-assembly segment. Bears counter that quarterly bookings are contracting at a nearly 10% annual rate, that the book-to-bill ratio has deteriorated, and that key revenue segments including SCAR and ADTS have declined — raising questions about whether the operating improvement is sustainable. EPS momentum ranks in the 97th-98th percentile on ORTEX factor scores, which supports the bull case near-term, but the EV/EBITDA of 31x still trails the small- and mid-cap defense peer average of roughly 49x, pointing to either a valuation catch-up story or a warranted discount depending on which side of the bookings debate you sit.
One institutional detail worth flagging: Jana Partners, a board-represented activist that held nearly 7% of shares at its peak, reported a significant reduction to 6.84% as of March and has been selling since early March in block trades totalling over $40 million. BlackRock, meanwhile, added 450,000 shares in the most recent reporting period to reach 15.6% of the company — the passive giants absorbing what the activists are distributing.
The August 18 print is therefore a test of whether the bookings trajectory has stabilised enough to justify a stock that has already priced in the operational recovery — and whether the gap between Goldman's bear case and the Street's growing Overweight camp is about to narrow or widen.
See the live data behind this article on ORTEX.
Open MRCY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
